Renaissance Capital logo

SHPH News

US IPO Weekly Recap: Summer IPO market ends with more small deals

ALEF

The long Labor Day weekend is here, which means the summer IPO market has come to an end. Four small issuers began trading this past week, although only two met our tracking criteria. Just two IPOs and one SPAC submitted initial filings. The most notable news of the week came from the pipeline. Digital ad firm Aleph Group (ALEF) and car sharing platform...read more

Radiation therapy-focused biotech Shuttle Pharmaceuticals prices IPO at $8.13

SHPH

Shuttle Pharmaceuticals, a Phase 2-ready biotech developing drugs to improve radiation therapy, raised $10 million by offering 1.2 million units at $8.13, as expected. Each unit consists of one share of common stock and one warrant, exercisable at $0.01. The company revised terms several times ahead of pricing, originally planning to offer 3 million shares at a range of $4...read more

Radiation therapy-focused biotech Shuttle Pharmaceuticals increases valuation ahead of proposed $10 million IPO

SHPH

Shuttle Pharmaceuticals, a Phase 2-ready biotech developing drugs to improve radiation therapy, raised the proposed price and lowered the unit offering for its upcoming IPO on Wednesday. The company also added China-based Valuable Capital as an underwriter on the deal. The Rockville, MD-based company now plans to raise $10 million by offering 1.2 million units at $8. The...read more

Radiation therapy-focused biotech Shuttle Pharmaceuticals lowers deal size, adds warrants ahead of $10 million IPO

SHPH

Shuttle Pharmaceuticals, a Phase 2-ready biotech developing drugs to improve radiation therapy, lowered the proposed deal size for its upcoming IPO on Friday. The Rockville, MD-based company now plans to raise $10 million by offering 1.7 million units at $6. Each unit consists of one share of common stock and one warrant, exercisable at $0.01. The company had most recently filed...read more